Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Dec 18 2020

Full Issue

Spain Passes Last Major Hurdle To Legalize Euthanasia

Other global news is from the United Kingdom, European Union, Africa and the West Bank.

AP: Spain's Parliament Votes To Legalize Euthanasia

Spain’s parliament voted Thursday to approve a bill that will allow physician-assisted suicide and euthanasia for long-suffering patients of incurable diseases or unbearable permanent conditions. The bill, which was backed by Spain’s left-wing coalition government and several other parties, passed in a 198-138 vote. The conservative Popular Party and the far-right Vox party voted “No.” The bill will now continue its legislative journey, facing a vote in the Senate where it is also expected to pass. According to the draft of the law approved by the lower house, it won’t go into effect until three months after being published in the government gazette. (12/17)

Also —

The Washington Post: How To Convince Coronavirus Vaccine Skeptics? U.K. Considers Influencers And Cash Incentives. 

In the first week in the first mass coronavirus vaccine campaign in the West, Britain's National Health Service gave the Pfizer-BioNTech shot to 137,897 people. British officials say they want everyone to have the jab. So that means 66 million more to go. How do you persuade a nation to take a vaccine — especially brand-new vaccines, granted emergency authorization — at a time of soaring distrust in leaders and institutions, when a third of the people tell survey takers they will either decline the vaccine or wait and see? Public health experts don’t have a surefire answer. And that worries them. (Adam and Booth, 12/16)

Reuters: 'I Feel Fine' - Beatles Legend McCartney Gives COVID Vaccine A Shot In The Arm 

Beatles legend Paul McCartney, 78, gave Britain’s COVID-19 vaccine rollout a big shot in the arm by vowing to be among the first global superstars to be inoculated, The Sun newspaper reported on Friday. (12/18)

AP: EU Clears Google's $2.1B Takeover Of Fitbit, With Conditions

The European Union on Thursday approved Google’s plan to buy fitness gadget maker Fitbit for $2.1 billion after it promised to restrict user data and ensure Android phones work with other wearable devices for at least 10 years. Human rights and consumer groups, which had called on authorities to block the deal over privacy and antitrust concerns, were unhappy with the decision. The deal also attracted scrutiny in Australia, where competition regulators are mulling a similar offer from Google. (Chan, 12/17)

The Washington Post: Across Much Of Africa, Coronavirus Vaccines Are Still Months Away 

In the pandemic's early days, scientists across Africa were certain: They did not want to rely on vaccines from abroad. Richer countries could hoard supplies, they feared, leaving nations with tighter research budgets behind. ... Distribution campaigns across Africa are not likely to begin until April, the head of the Africa Centers for Disease Control and Prevention estimated. Even then, far fewer doses will be sent to African countries than are being shipped to the United States and Europe. “It will be extremely terrible to see,” said John Nkengasong, the Africa CDC director. (Paquette and Bearak, 12/17)

AP: Lockdown Looms Over Christmas In Bethlehem

The mayor of Bethlehem on Thursday said Christmas celebrations in the birthplace of Jesus will be limited to just a handful of people this year as Palestinian officials announced a strict new lockdown across the West Bank due to a soaring coronavirus outbreak. In an interview, Mayor Anton Salman said his town would hold its traditional welcoming ceremony for the Latin Patriarch, who is usually greeted by children’s marching bands as he arrives from nearby Jerusalem. But he said the scout bands would be limited only to local residents because of the new lockdown restrictions. (12/17)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF